Nanjing Hicin Pharmaceutical Co., Ltd. Announces Appointments of Non-Independent Director, Independent Director and Non-Employee Supervisor Candidates
July 17, 2019 at 11:37 am EDT
Share
Nanjing Hicin Pharmaceutical Co., Ltd. at its Extraordinary General Meeting held on July 16, 2019 announced appointments of non-independent director, independent director and non-employee supervisor candidates. Cao Yuping, Cao Yuping, Jiang Xiaoqun, Liu Xiaoquan, Yao Xiaomin, Wang Yongjun appointed as non-independent director. Zhao Ming, Li Xiang, Zhou Hao were appointed as independent director. Feng Mingsheng and Zhu Liye were appointed as non-employee supervisor candidates.
Nanjing Hicin Pharmaceutical Co Ltd is a pharmaceutical company engaged in research, development and production of chemical preparations, active pharmaceutical ingredients and intermediates. The Company's primary products are torsemide for injection, tigecycline for injection, cefoxitin sodium for injection, cefotiam for injection and omeprazole sodium for injection. The torsemide for injection is a loop diuretic. The tigecycline for injection is an intravenous administrated glycyrrhizin antibiotic for the treatment of complex skin and skin structure infections or complex intra-abdominal infections. The cefoxitin sodium for injection is a cephalosporin antibiotic used for the treatment of respiratory, urinary and gastrointestinal infections. Its products cover a range of therapeutic areas, including diuresis, cardiovascular, anti-infection, digestive system, immune regulation, hypoglycemic and orthopedics.
NANJING HICIN PHARMACEUTICAL CO., LTD. 
